United Therapeutics Corp


Market Cap$12.76B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
United Therapeutics CorpUnited Therapeutics Corp12.10%20%5.50.1

Target Price by Analysts

22.5% upsideUnited Therapeutics Target Price DetailsTarget Price

Current Fair Value

36.5% upside

Undervalued by 36.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.76 Billion
Enterprise Value$10.65 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$21.13
Outstanding Shares44,355,694
Avg 30 Day Volume536,792


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio12.14
Price to Sales5.47
Price to Book Ratio2.55
Enterprise Value to Revenue4.26
Enterprise Value to EBIT8.47
Enterprise Value to Net Income10
Total Debt to Enterprise0.06
Debt to Equity0.11

Revenue Sources

No data

Insider Trades

ESG Score

No data

About United Therapeutics Corp

920 employees
CEO: Martine Rothblatt

United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power o...